The US Biomedical Advanced Research and Development Authority (BARDA) has awarded $10 million to Israel’s MediWound (see here previously). Part of the funding will be used to extend its NexoBrid license to pediatric burns – 30% of the total burn population.
Extending burns wound treatment to children
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.